
### [NCIT:C3212](http://purl.obolibrary.org/obo/NCIT_C3212)
**Label:** Lymphoplasmacytic Lymphoma

**Subclasses:** [NCIT:C8604](http://purl.obolibrary.org/obo/NCIT_C8604) (Recurrent Lymphoplasmacytic Lymphoma), [NCIT:C8656](http://purl.obolibrary.org/obo/NCIT_C8656) (Stage IV Lymphoplasmacytic Lymphoma), [NCIT:C7305](http://purl.obolibrary.org/obo/NCIT_C7305) (Splenic Lymphoplasmacytic Lymphoma), [NCIT:C8654](http://purl.obolibrary.org/obo/NCIT_C8654) (Stage II Lymphoplasmacytic Lymphoma), [NCIT:C115212](http://purl.obolibrary.org/obo/NCIT_C115212) (Familial Waldenstrom Macroglobulinemia), [NCIT:C8655](http://purl.obolibrary.org/obo/NCIT_C8655) (Stage III Lymphoplasmacytic Lymphoma), [NCIT:C127840](http://purl.obolibrary.org/obo/NCIT_C127840) (Recurrent Waldenstrom Macroglobulinemia), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C8653](http://purl.obolibrary.org/obo/NCIT_C8653) (Stage I Lymphoplasmacytic Lymphoma), [NCIT:C80307](http://purl.obolibrary.org/obo/NCIT_C80307) (Waldenstrom Macroglobulinemia), 

**Class expressions from DL-Learner:**

- Thing 53.64%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 52.50%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 37.86%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 37.86%


